Apnimed, Inc.
NASDAQ:APMDBiotechnology
+$0.71 today
- Market cap
- $726.46M
- Beta
- 0.00
Volume 0.30M
Average 1.15M
APMD Deferred Revenue (Non-current)
Payments received for goods or services the company will deliver after more than one year.
Deferred Revenue (Non-current) history
Currency unavailable · from the balance sheet
No Deferred Revenue (Non-current) data reported for this period type.
Deferred Revenue (Non-current) vs competitors
How APMD compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | €711.69K EUR | +156.9% | — | 0.7% | |
| Jun 2026 | $0 USD | — | — | 0.0% | |
APMDApnimed, Inc. | — | — | — | — | — |
| Peer median (excluding APMD) | — | +156.9% | — | 0.4% | |
Competitors are the stored peer set for APMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Apnimed, Inc.
NASDAQ:APMD
Intrinsic Alpha fair value
Locked
Current Price
$17.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.